As part of a global effort to better align manufacturing capacity with the future needs of its business, Pfizer announced Wednesday the phased shutdown of its Barceloneta manufacturing plant by the end of 2017.
Merck’s pharmaceutical operations in Puerto Rico are ramping up their production capacity with the recent addition of Liptruzet cholesterol inhibiting tablets, which are being manufactured in Las Piedras, Andrew Wirths, general manager of the company on the island, said Wednesday.
Promoting healthy habits and providing access to basic and specialized medical services to children in vulnerable communities is the mission of “Proyecto Creceré,” an initiative unveiled Tuesday by the Extra Bases Foundation — established by famed Puerto Rican baseballer Carlos Delgado — Merck, the University of Puerto Rico’s School of Pharmacy and the Association of Pediatricians of the West.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
